NCT05017987View on ClinicalTrials.gov

Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 19, 2021

Primary Completion Date

July 12, 2021

Study Completion Date

July 12, 2021

Conditions

Healthy Adult Volunteers

Interventions

DRUG

ATB-101, ATB-1011, ATB-1012

"1. Test drug~ \- Code name: ATB-101~2. Control drug1~ * Code name: ATB-1011~ * Active ingredient: Olmesartan~3. Control drug2~ * Code name: ATB-1012~ * Active ingredient: Dapagliflozin"

Trial Locations (1)

08779

H Plus Yangji Hospital, Seoul